Our commitment to haemophilia

Changing Haemophilia® represents Novo Nordisk’s commitment to the entire haemophilia community, encompassing all the company’s activities from developing new treatments to supporting community projects to improve the lives of people with haemophilia and allied bleeding disorders.

We work towards a future in which all people with haemophilia, whether reliant on inhibitors or not, can live their lives with the least possible impediment.

Our objectives are:

  • to advance treatment and care through innovation
  • to improve access to diagnosis, care and treatment
  • to improve the understanding of these conditions in the broader society

 

UK/WB/0813/0020a(1)  April 2016


A Novo Nordisk initiative covering all our work towards a future where everyone living with haemophilia can lead the life they wish.

Read more